You are here: Home / News / FDA sees varying risk from MRI agents

FDA sees varying risk from MRI agents

November 17, 2009 By

Related posts:

  1. Greater risks seen with certain imaging agents: FDA
  2. U.S. panel sees higher skin risk with some MRI drugs
  3. Researcher sees cancer risk for Medtronic’s Infuse
  4. U.S. sees rise in secondary infections after flu
  5. FDA sees rare but serious issue with stents

Filed Under: News Tagged With: ,